Cargando…

Correlation between changes of blood pressure with insulin resistance in type 2 diabetes mellitus with 4 weeks of pioglitazone therapy

OBJECTIVE: To examine effects of pioglitazone (PIO) on systolic, diastolic, pulse and mean blood pressures (SBP, DBP, PP and MP, respectively) in type 2 diabetes mellitus (T2DM). MATERIALS AND METHODS: One hundred and six normotensive patients with T2DM with mean fasting blood glucose (FBS; 183 ± 6...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hettihewa, L. M., Jayasinghe, S. S., Imendra, K. G., Weerarathna, T. P.
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2008
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2772002/ https://www.ncbi.nlm.nih.gov/pubmed/19902036 http://dx.doi.org/10.4103/0973-3930.41983

Ejemplares similares

Correlation between changes in blood pressure with insulin resistance in type 2 diabetes mellitus with four weeks of pioglitazone therapy
por: Dash, Sandip Kumar
Publicado: (2008)

Comparison of McAuley/fasting insulin indices with ATP III clinical criteria for the diagnosis of insulin resistance in type 2 diabetes mellitus
por: Hettihewa, L. M., et al.
Publicado: (2011)

Concomitant therapy with pioglitazone and insulin for the treatment of type 2 diabetes
por: Yamanouchi, Toshikazu
Publicado: (2010)

Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis
por: Gaebler, Julia A, et al.
Publicado: (2012)

Prevention of Diabetes With Pioglitazone in ACT NOW: Physiologic Correlates
por: DeFronzo, Ralph A., et al.
Publicado: (2013)

Blood-Pressure Variation and Cardiovascular Changes in Diabetes Mellitus
por: Chakravarti, Amal
Publicado: (1945)

Pioglitazone Increases Whole Body Insulin Sensitivity in Obese, Insulin-Resistant Rhesus Monkeys
por: Tozzo, Effie, et al.
Publicado: (2015)

Correlation of Insulin Resistance with Anthropometric Measures and Blood Pressure in Adolescents
por: de Morais, Polyana Resende Silva, et al.
Publicado: (2016)

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
por: Holland, Daniel Q, et al.
Publicado: (2014)

Effect of Pioglitazone on the Course of New-Onset Type 1 Diabetes Mellitus
por: Tafuri, Kimberly Sue, et al.
Publicado: (2013)

Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
por: Schwartz, Stanley S
Publicado: (2010)

Hypoglycemic, hypolipidemic and antioxidant effects of pioglitazone, insulin and synbiotic in diabetic rats
por: Kavitha, K., et al.
Publicado: (2016)

Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus
por: Zhang, Zhengjun, et al.
Publicado: (2018)

Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus
por: Park, Jong Suk, et al.
Publicado: (2011)

The Effects of Pioglitazone on Bone Formation and Resorption Markers in Type 2 Diabetes Mellitus
por: Mori, Hiroko, et al.
Publicado: (2017)

The effects of insulin therapy on maternal blood pressure and weight in women with gestational diabetes mellitus
por: Sun, Tiange, et al.
Publicado: (2021)

Higher Fetal Insulin Resistance in Chinese Pregnant Women with Gestational Diabetes Mellitus and Correlation with Maternal Insulin Resistance
por: Wang, Qiuwei, et al.
Publicado: (2013)

Pioglitazone and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: a systematic review and meta-analysis
por: Liao, Hung-Wei, et al.
Publicado: (2017)

Prevalence of gestational diabetes mellitus and its correlation with blood pressure in Manipuri women
por: Vanlalhruaii,, et al.
Publicado: (2013)

Correlation between Insulin Resistance and Thyroid Nodule in Type 2 Diabetes Mellitus
por: Tang, Yunzhao, et al.
Publicado: (2017)

An insulin resistance associated neural correlate of impulsivity in type 2 diabetes mellitus
por: Eckstrand, Kristen L., et al.
Publicado: (2017)

Patient factors associated with hemoglobin A1C change with pioglitazone as adjunctive therapy in type 2 Diabetes Mellitus
por: Tran, Mongthuong T., et al.
Publicado: (2008)

Efficacy and safety of teneligliptin in combination with pioglitazone in Japanese patients with type 2 diabetes mellitus
por: Kadowaki, Takashi, et al.
Publicado: (2013)

Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus
por: Kim, Kyung-Soo, et al.
Publicado: (2020)

Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis
por: Lian, Jingxuan, et al.
Publicado: (2021)

Pioglitazone alters fat distribution in patients with type 2 diabetes mellitus, in contrast to metformin
por: Jonker, Jacqueline T, et al.
Publicado: (2009)

Effects of Exercise, Metformin, Pioglitazone and Exenatide Treatment on Inflammation Induced Insulin Resistance and Ubiquitin Proteasome System in Diabetes and Obesity
por: Akarsu, Ersin, et al.
Publicado: (2021)

Attainment of recommended therapeutic targets of modifiable cardiovascular risk factors among individuals with type 2 diabetes mellitus screened at a diabetes clinic in Sri Lanka
por: Weerarathna, Thilak Priyantha, et al.
Publicado: (2018)

Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone
por: Forst, T, et al.
Publicado: (2014)

Pioglitazone Induces Dysplastic Urothelial Changes in Urinary Bladder of Experimental Diabetes
por: Abdel-Hamid, Ahmed A. M., et al.
Publicado: (2021)

Corrigendum: Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis
por: Lian, Jingxuan, et al.
Publicado: (2022)

Adding Pioglitazone to Insulin Containing Regimens in Type 2 Diabetes: Systematic Review and Meta-Analysis
por: Clar, Christine, et al.
Publicado: (2009)

Pioglitazone use increases risk of Alzheimer's disease in patients with type 2 diabetes receiving insulin
por: Lin, Hsin-Chung, et al.
Publicado: (2023)

Pioglitazone Acutely Reduces Energy Metabolism and Insulin Secretion in Rats
por: Lamontagne, Julien, et al.
Publicado: (2013)

Effects of Pioglitazone on Insulin Sensitivity and Serum Lipids in Obese Cats
por: Clark, M., et al.
Publicado: (2013)

The Insulin-Sensitizer Pioglitazone Remodels Adipose Tissue Phospholipids in Humans
por: Palavicini, Juan P., et al.
Publicado: (2021)

Insulin Resistance and Diabetes Mellitus in Alzheimer’s Disease
por: Burillo, Jesús, et al.
Publicado: (2021)

Salt-Sensitivity of Blood Pressure and Insulin Resistance
por: Ertuglu, Lale A., et al.
Publicado: (2021)

Effects of pioglitazone treatment on blood leptin levels in patients with type 2 diabetes
por: Ida, Satoshi, et al.
Publicado: (2017)

Sodium‐glucose cotransporter 2 inhibitor plus pioglitazone vs pioglitazone alone in patients with diabetes mellitus: A systematic review and meta‐analysis of randomized controlled trials
por: Liao, Hung‐Wei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_39bckfuatjkmra7rkgv86udsud